论文部分内容阅读
对127例IgA肾病(IgAN)患者和25例非IgA系膜增殖性肾炎血清进行了抗内皮细胞抗体(AECA)的检测。结果表明:IgA肾病患者和非IgA系膜增殖性肾炎患者血清AECA-IgG较正常对照组高,而IgAN患者较非IgA系膜增殖性肾炎患者AECA-IgG的水平高,P<0.05。IgAN患者的AE-CA-IgA水平较正常对照组高。IgAN患者按AECA水平分为阳性与阴性组,对两组硬化面积比进行比较,未见明显差异。IgA肾病患者的AECA按不同年龄分组,按尿蛋白量的不同,分组进行比较,结果各组间未发现明显差异。
Anti-endothelial cell antibody (AECA) was detected in 127 IgA nephropathy (IgAN) patients and 25 non-IgA mesangial proliferative glomerulonephritis sera. The results showed that serum AECA-IgG levels in IgA nephropathy patients and non-IgA mesangial proliferative glomerulonephritis patients were higher than those in normal controls, while those in IgAN patients were higher than those in non-IgA mesangial proliferative glomerulonephritis patients (P <0.05). The level of AE-CA-IgA in IgAN patients was higher than that in normal controls. Patients with IgAN were divided into positive and negative groups according to the AECA level. There was no significant difference between the two groups in the hardened area ratio. AECA patients with IgA nephropathy according to different age groups, according to the different amount of urine protein, group comparison, the results were not significantly different between groups.